Abstract
Our previous studies have shown that the overexpression of ornithine decarboxylase (ODC), the rate-limiting enzyme in polyamine biosynthesis, increases the enzymatic activity of the polyamine-responsive enzyme casein kinase 2 (CK2). Because CK2 is known to preferentially associate with the nuclear matrix in response to other trophic stimuli, we investigated the effects of ODC overexpression on CK2 localisation and on the CK2-mediated phosphorylation of a known CK2 substrate, the nucleolar phosphoprotein B23. Immunofluorescence analysis of CK2 and B23 in primary keratinocytes revealed that ODC overexpression resulted in the colocalisation of CK2 with B23 at the nucleolar borders. ODC overexpression also increased CK2 kinase activity 2-fold at the nuclear matrix, a response which could be abrogated by treatment of K6/ODC transgenic keratinocytes with the ODC inhibitor α-difluoromethylornithine (DFMO). Levels of B23 protein were also elevated in ODC-overexpressing cells compared to normal cells or transgenic cells treated with DFMO. This increase in protein level was neither due to an increase in steady-state mRNA levels, nor was it due to increased stability of B23 protein. Phosphorylation of B23 was also increased in ODC-overexpressing cells, and this increased phosphorylation could be blocked by treatment of the cells with the CK2 kinase inhibitors apigenin or 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole (DRB). These data suggest that B23 may be a downstream effector of polyamines via phosphorylation by the protein kinase CK2.
Similar content being viewed by others
References
Pegg AE, McCann PP: Polyamine metabolism and function. Am J Physiol 243: C212–C221, 1982
Tabor CW, Tabor H: Polyamines. Annu Rev Biochem 53: 749–790, 1984
Marton LJ, Pegg AE: Polyamines as targets for therapeutic intervention. Annu Rev Pharmacol Toxicol 35: 55–91, 1995
Pena A, Reddy CD, Wu S, Hickok NJ, Reddy EP, Yumet G, Soprano DR, Soprano KJ: Regulation of human ornithine decarboxylase expression by the c-Myc.Max protein complex. J Biol Chem 268: 27277–27285, 1993
Tabib A, Bachrach U: Activation of the proto-oncogene c-myc and c-fos by c-ras: Involvement of polyamines. Biochem Biophys Res Commun 202: 720–727, 1994
Shantz LM, Pegg AE: Overproduction of ornithine decarboxylase caused by relief of translational repression is associated with neoplastic transformation. Cancer Res 54: 2313–2316, 1994
Auvinen M, Paasinen A, Andersson LC, Holtta E: Ornithine decarboxylase activity is critical for cell transformation. Nature 360: 355–358, 1992
Clifford A, Morgan D, Yuspa SH, Soler AP, Gilmour S: Role of ornithine decarboxylase in epidermal tumorigenesis. Cancer Res 55: 1680–1686, 1995
Smith MK, Trempus CS, Gilmour SK: Co-operation between follicular ornithine decarboxylase and v-Ha-ras induces spontaneous papillomas and malignant conversion in transgenic skin. Carcinogenesis 19: 1409–1415, 1998
Filhol O, Cochet C, Loue-Mackenbach P, Chambaz EM: Oligomeric casein kinase II isoforms are expressed in bovine tissues and adrenocortical cells in culture. Biochem Biophys Res Commun 198: 660–665, 1994
Canton DA, Zhang C, Litchfield DW: Assembly of protein kinase CK2: Investigation of complex formation between catalytic and regulatory subunits using a zinc-finger-deficient mutant of CK2beta. Biochem J 358: 87–94, 2001
Cochet C, Chambaz EM: Oligomeric structure and catalytic activity of G type casein kinase. Isolation of the two subunits and renaturation experiments. J Biol Chem 258: 1403–1406, 1983
Leroy D, Schmid N, Behr JP, Filhol O, Pares S, Garin J, Bourgarit JJ, Chambaz EM, Cochet C: Direct identification of a polyamine binding domain on the regulatory subunit of the protein kinase casein kinase 2 by photoaffinity labeling. J Biol Chem 270: 17400–17406, 1995
Leroy D, Filhol O, Delcros JG, Pares S, Chambaz EM, Cochet C: Chemical features of the protein kinase CK2 polyamine binding site. Biochemistry 36: 1242–1250, 1997
Leroy D, Heriche JK, Filhol O, Chambaz EM, Cochet C: Binding of polyamines to an autonomous domain of the regulatory subunit of protein kinase CK2 induces a conformational change in the holoenzyme. A proposed role for the kinase stimulation. J Biol Chem 272: 20820–20827, 1997
Shore LJ, Soler AP, Gilmour SK: Ornithine decarboxylase expression leads to translocation and activation of protein kinase CK2 in vivo. J Biol Chem 272: 12536–12543, 1997
Praskova M, Kalenderova S, Miteva L, Poumay Y, Mitev V: The ornithine decarboxylase inhibitor, difluoromethylornithine, inhibits casein kinase II activity, c-Myc expression and normal human keratinocyte proliferation. Arch Dermatol Res 293: 590–593, 2002
Siemer S, Kriener S, Konig J, Remberger K, Issinger OG: Influence of indomethacin and difluoromethylornithine on human tumour growth in nude mice. Eur J Cancer 31A: 976–981, 1995
Munstermann U, Fritz G, Seitz G, Lu YP, Schneider HR, Issinger OG: Casein kinase II is elevated in solid human tumours and rapidly proliferating non-neoplastic tissue. Eur J Biochem 189: 251–257, 1990
Gapany M, Faust RA, Tawfic S, Davis A, Adams GL, Ahmed K: Association of elevated protein kinase CK2 activity with aggressive behavior of squamous cell carcinoma of the head and neck. Mol Med 1: 659–666, 1995
Issinger OG: Casein kinases: Pleiotropic mediators of cellular regulation. Pharmacol Ther 59: 1–30, 1993
Orlandini M, Semplici F, Ferruzzi R, Meggio F, Pinna LA, Oliviero S: Protein kinase CK2alpha’ is induced by serum as a delayed early gene and cooperates with Ha-ras in fibroblast transformation. J Biol Chem 273: 21291–21297, 1998
Landesman-Bollag E, Channavajhala PL, Cardiff RD, Seldin DC: p53 deficiency and misexpression of protein kinase CK2alpha collaborate in the development of thymic lymphomas in mice. Oncogene 16: 2965–2974, 1998
Wang H, Davis A, Yu S, Ahmed K: Response of cancer cells to molecular interruption of the CK2 signal. Mol Cell Biochem 227: 167–174, 2001
Guo C, Yu S, Davis AT, Wang H, Green JE, Ahmed K: A potential role of nuclear matrix-associated protein kinase CK2 in protection against drug-induced apoptosis in cancer cells. J Biol Chem 276: 5992–5999, 2001
Litchfield DW: Protein kinase CK2: Structure, regulation and role in cellular decisions of life and death. Biochem J 369: 1–15, 2003
Farah M, Parhar K, Moussavi M, Eivemark S, Salh B: 5,6-Dichloro-ribifuranosylbenzimidazole- and apigenin-induced sensitization of colon cancer cells to TNF-alpha-mediated apoptosis. Am J Physiol Gastrointest Liver Physiol 285: G919–G928, 2003
Perea SE, Reyes O, Puchades Y, Mendoza O, Vispo NS, Torrens I, Santos A, Silva R, Acevedo B, Lopez E, Falcon V, Alonso DF: Antitumor effect of a novel proapoptotic peptide that impairs the phosphorylation by the protein kinase 2 (casein kinase 2). Cancer Res 64: 7127–7129, 2004
Buchou T, Vernet M, Blond O, Jensen HH, Pointu H, Olsen BB, Cochet C, Issinger OG, Boldyreff B: Disruption of the regulatory beta subunit of protein kinase CK2 in mice leads to a cell-autonomous defect and early embryonic lethality. Mol Cell Biol 23: 908–915, 2003
Belenguer P, Baldin V, Mathieu C, Prats H, Bensaid M, Bouche G, Amalric F: Protein kinase NII and the regulation of rDNA transcription in mammalian cells. Nucleic Acids Res 17: 6625–6636, 1989
Filhol O, Cochet C, Chambaz EM: Cytoplasmic and nuclear distribution of casein kinase II: Characterization of the enzyme uptake by bovine adrenocortical nuclear preparation. Biochemistry 29: 9928–9936, 1990
Pepperkok R, Lorenz P, Ansorge W, Pyerin W: Casein kinase II is required for transition of G0/G1, early G1, and G1/S phases of the cell cycle. J Biol Chem 269: 6986–6991, 1994
Lorenz P, Ackermann K, Simoes-Wuest P, Pyerin W: Serum-stimulated cell cycle entry of fibroblasts requires undisturbed phosphorylation and non-phosphorylation interactions of the catalytic subunits of protein kinase CK2. FEBS Lett 448: 283–288, 1999
Meisner H, Czech MP: Phosphorylation of transcriptional factors and cell-cycle-dependent proteins by casein kinase II. Curr Opin Cell Biol 3: 474–483, 1991
Pinna LA, Meggio F: Protein kinase CK2 (“casein kinase-2”) and its implication in cell division and proliferation. Prog Cell Cycle Res 3: 77–97, 1997
Zatsepina OV, Todorov IT, Philipova RN, Krachmarov CP, Trendelenburg MF, Jordan EG: Cell cycle-dependent translocations of a major nucleolar phosphoprotein, B23, and some characteristics of its variants. Eur J Cell Biol 73: 58–70, 1997
Yung BY, Busch H, Chan PK: Translocation of nucleolar phosphoprotein B23 (37 kDa/pI 5.1) induced by selective inhibitors of ribosome synthesis. Biochim Biophys Acta 826: 167–173, 1985
Herrera JE, Savkur R, Olson MO: The ribonuclease activity of nucleolar protein B23. Nucleic Acids Res 23: 3974–3979, 1995
Finch RA, Chan PK: ATP depletion affects NPM translocation and exportation of rRNA from nuclei. Biochem Biophys Res Commun 222: 553–558, 1996
Szebeni A, Hingorani K, Negi S, Olson MO: Role of protein kinase CK2 phosphorylation in the molecular chaperone activity of nucleolar protein b23. J Biol Chem 278: 9107–9115, 2003
Szebeni A, Mehrotra B, Baumann A, Adam SA, Wingfield PT, Olson MO: Nucleolar protein B23 stimulates nuclear import of the HIV-1 Rev protein and NLS-conjugated albumin. Biochemistry 36: 3941–3949, 1997
Szebeni A, Herrera JE, Olson MO: Interaction of nucleolar protein B23 with peptides related to nuclear localization signals. Biochemistry 34: 8037–8042, 1995
Tawfic S, Ahmed K: Growth stimulus-mediated differential translocation of casein kinase 2 to the nuclear matrix. Evidence based on androgen action in the prostate. J Biol Chem 269: 24615–24620, 1994
Feuerstein N, Randazzo PA: In vivo and in vitro phosphorylation studies of numatrin, a cell cycle regulated nuclear protein, in insulin-stimulated NIH 3T3 HIR cells. Exp Cell Res 194: 289–296, 1991
Yuspa SH, Harris CC: Altered differentiation of mouse epidermal cells treated with retinyl acetate in vitro. Exp Cell Res 86: 95–105, 1974
Chan PK, Aldrich M, Busch H: Alterations in immunolocalization of the phosphoprotein B23 in HeLa cells during serum starvation. Exp Cell Res 161: 101–110, 1985
Li D, Meier UT, Dobrowolska G, Krebs EG: Specific interaction between casein kinase 2 and the nucleolar protein Nopp140. J Biol Chem 272: 3773–2779, 1997
Caizergues-Ferrer M, Belenguer P, Lapeyre B, Amalric F, Wallace MO, Olson MO: Phosphorylation of nucleolin by a nucleolar type NII protein kinase. Biochemistry 26: 7876–7883, 1987
Jiang PS, Chang JH, Yung BY: Different kinases phosphorylate nucleophosmin/B23 at different sites during G(2) and M phases of the cell cycle. Cancer Lett 153: 151–160, 2000
Tawfic S, Olson MO, Ahmed K: Role of protein phosphorylation in post-translational regulation of protein B23 during programmed cell death in the prostate gland. J Biol Chem 270: 21009–21015, 1995
Meijer L, Borgne A, Mulner O, Chong JP, Blow JJ, Inagaki N, Inagaki M, Delcros JG, Moulinoux JP: Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5. Eur J Biochem 243: 527–536, 1997
Yenice S, Davis AT, Goueli SA, Akdas A, Limas C, Ahmed K: Nuclear casein kinase 2 (CK-2) activity in human normal, benign hyperplastic, and cancerous prostate. Prostate 24: 11–16, 1994
Ahmed K, Yenice S, Davis A, Goueli SA: Association of casein kinase 2 with nuclear chromatin in relation to androgenic regulation of rat prostate. Proc Natl Acad Sci USA 90: 4426–4430, 1993
Tawfic S, Faust RA, Gapany M, Ahmed K: Nuclear matrix as an anchor for protein kinase CK2 nuclear signalling. J Cell Biochem 62: 165–171, 1996
Chan PK, Liu QR, Durban E: The major phosphorylation site of nucleophosmin (B23) is phosphorylated by a nuclear kinase II. Biochem J 270: 549–552, 1990
Biggiogera M, Fakan S, Kaufmann SH, Black A, Shaper JH, Busch H: Simultaneous immunoelectron microscopic visualization of protein B23 and C23 distribution in the HeLa cell nucleolus. J Histochem Cytochem 37: 1371–1374, 1989
Meier UT, Blobel G: Nopp140 shuttles on tracks between nucleolus and cytoplasm. Cell 70: 127–138, 1992
Borer RA, Lehner CF, Eppenberger HM, Nigg EA: Major nucleolar proteins shuttle between nucleus and cytoplasm. Cell 56: 379–390, 1989
Yun JP, Chew EC, Liew CT, Chan JY, Jin ML, Ding MX, Fai YH, Li HK, Liang XM, Wu QL: Nucleophosmin/B23 is a proliferate shuttle protein associated with nuclear matrix. J Cell Biochem 90: 1140–1148, 2003
Feuerstein N, Mond JJ: “Numatrin,” a nuclear matrix protein associated with induction of proliferation in B lymphocytes. J Biol Chem 262: 11389–11397, 1987
Chan WY, Liu QR, Borjigin J, Busch H, Rennert OM, Tease LA, Chan PK: Characterization of the cDNA encoding human nucleophosmin and studies of its role in normal and abnormal growth. Biochemistry 28: 1033–1039, 1989
Igarashi K, Kashiwagi K: Polyamines: Mysterious modulators of cellular functions. Biochem Biophys Res Commun 271: 559–564, 2000
Igarashi K, Saisho T, Yuguchi M, Kashiwagi K: Molecular mechanism of polyamine stimulation of the synthesis of oligopeptide-binding protein. J Biol Chem 272: 4058–4064, 1997
Yoshida M, Kashiwagi K, Kawai G, Ishihama A, Igarashi K: Polyamine enhancement of the synthesis of adenylate cyclase at the translational level and the consequential stimulation of the synthesis of the RNA polymerase sigma 28 subunit. J Biol Chem 276: 16289–16295, 2001
Stjernborg L, Heby O, Holm I, Persson L: On the translational control of ornithine decarboxylase expression by polyamines. Biochim Biophys Acta 1090: 188–194, 1991
Tokuyama Y, Horn HF, Kawamura K, Tarapore P, Fukasawa K: Specific phosphorylation of nucleophosmin on Thr(199) by cyclin-dependent kinase 2-cyclin E and its role in centrosome duplication. J Biol Chem 276: 21529–21537, 2001
Meggio F, Boldyreff B, Issinger OG, Pinna LA: The autophosphorylation and p34cdc2 phosphorylation sites of casein kinase-2 beta-subunit are not essential for reconstituting the fully-active heterotetrameric holoenzyme. Biochim Biophys Acta 1164: 223–225, 1993
Sayed M, Kim SO, Salh BS, Issinger OG, Pelech SL: Stress-induced activation of protein kinase CK2 by direct interaction with p38 mitogen-activated protein kinase. J Biol Chem 275: 16569–16573, 2000
Bonnet H, Filhol O, Truchet I, Brethenou P, Cochet C, Amalric F, Bouche G: Fibroblast growth factor-2 binds to the regulatory beta subunit of CK2 and directly stimulates CK2 activity toward nucleolin. J Biol Chem 271: 24781–24787, 1996
Szebeni A, Olson MO: Nucleolar protein B23 has molecular chaperone activities. Protein Sci 8: 905–912, 1999
Russell DH: Microinjection of purified ornithine decarboxylase into Xenopus oocytes selectively stimulates ribosomal RNA synthesis. Proc Natl Acad Sci USA 80: 1318–1321, 1983
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lawson, K., Larentowicz, L., Laury-Kleintop, L. et al. B23 is a downstream target of polyamine- modulated CK2. Mol Cell Biochem 274, 103–114 (2005). https://doi.org/10.1007/s11010-005-3066-4
Issue Date:
DOI: https://doi.org/10.1007/s11010-005-3066-4